Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
2.620
+0.120 (4.80%)
Sep 2, 2026, 4:00 PM EDT - Market closed
Serina Therapeutics Employees
Serina Therapeutics had 16 employees as of December 31, 2025. The number of employees increased by 3 or 23.08% compared to the previous year.
Employees
16
Change (1Y)
3
Growth (1Y)
23.08%
Revenue / Employee
n/a
Profits / Employee
-$1,495,313
Market Cap
66.55M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 16 | 3 | 23.08% | 16 | 0 |
| Dec 31, 2024 | 13 | 2 | 18.18% | 12 | 1 |
| Dec 31, 2023 | 11 | - | - | 9 | 2 |
| Sep 30, 2023 | 9 | - | - | 5 | 4 |
| Jun 30, 2023 | 9 | - | - | 5 | 4 |
Related Stocks
| Company Name | Employees |
|---|---|
| Alps Group | 93 |
| MindWalk Holdings | 77 |
| Elicio Therapeutics | 33 |
| eXoZymes | 32 |
| Boundless Bio | 28 |
| INmune Bio | 21 |
| iBio, Inc. | 20 |
| Edesa Biotech | 17 |
SER News
- 9 days ago - Serina Therapeutics files to sell 12.5M shares of common stock for holders - TheFly
- 9 days ago - Serina Therapeutics Registration statement: Registration filing - Filings
- 20 days ago - Serina Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 20 days ago - Serina Therapeutics Quarterly report: Q2 2026 - Filings
- 20 days ago - Serina Therapeutics Earnings release: Q2 2026 - Filings
- 5 weeks ago - Serina Therapeutics to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewsWire
- 5 weeks ago - Serina Therapeutics completes enrollment and dosing in Parkinson’s trial - TheFly
- 5 weeks ago - Serina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of SER-252 for Advanced Parkinson's Disease - GlobeNewsWire